top of page

REYATAZ CAPSULE 300MG

Product details

Registration number: SIN13560P

Classification: Prescription Only

Active ingredients: ATAZANAVIR SULFATE 341.69 mg EQV ATAZANAVIR

Strength: 300 mg

Dosage form: CAPSULE

Route: ORAL

Registrant: BRISTOL-MYERS SQUIBB (SINGAPORE) PTE. LTD.

ATC code: J05AE08

HSA approval date: 8 October 2008

Manufacturer(s):

  • AstraZeneca Pharmaceuticals LP
  • AndersonBrecon Incorporated (Primary and Secondary Packager)
  • Patheon Inc.

Manufacturing country/countries: UNITED STATES; CANADA

What are the HSA registration number and classification for REYATAZ CAPSULE 300MG?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN13560P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for REYATAZ CAPSULE 300MG?

According to the HSA dataset updated 7 August 2026:

Active ingredients: ATAZANAVIR SULFATE 341.69 mg EQV ATAZANAVIR

Strength: 300 mg

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for REYATAZ CAPSULE 300MG?

According to the HSA dataset updated 7 August 2026:

Dosage form: CAPSULE

Route: ORAL

Source for this answer

Who is the recorded registrant for REYATAZ CAPSULE 300MG?

According to the HSA dataset updated 7 August 2026:

Registrant: BRISTOL-MYERS SQUIBB (SINGAPORE) PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for REYATAZ CAPSULE 300MG?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • AstraZeneca Pharmaceuticals LP
  • AndersonBrecon Incorporated (Primary and Secondary Packager)
  • Patheon Inc.

Manufacturing country/countries: UNITED STATES; CANADA

Source for this answer

Where can I look up REYATAZ CAPSULE 300MG in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN13560P or the exact product name REYATAZ CAPSULE 300MG. The general register link does not preselect this product.

Source for this answer

What are the source dates for this REYATAZ CAPSULE 300MG record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this REYATAZ CAPSULE 300MG record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN13560P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page